Avantor (AVTR) Fundamentals 2026 — Revenue Analysis | SniperIQ

0.96 on the NYSE. This SniperIQ fundamentals page covers Avantor's valuation, profitability (net margin -8.4%), revenue ($6.6B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Full research coverage

• 8-Quarter Revenue & Margin Trend
• Debt Maturity & Coverage
• Peer Valuation Comparison
• Free Cash Flow & Owner Earnings
• AI Signal + Institutional Flow
• DCF Valuation Model

Frequently Asked Questions

What is Avantor's market cap?

Avantor (AVTR) has a market capitalization of approximately $7.5B, trading at

0.96 on the NYSE. Market cap moves with the live share price.

What is Avantor's P/E ratio?

Avantor's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 1.3x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is Avantor?

Avantor runs a net profit margin of -8.4%, a gross margin of 32.1%, and an operating margin of -4.3%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Avantor generate?

Avantor reported revenue of $6.6B for fiscal year 2025, with net income of -$530M and earnings per share (EPS) of -0.78. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Avantor pay a dividend?

Avantor does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.

Is Avantor financially healthy?

Avantor carries a debt-to-equity ratio of 0.68x and a current ratio of 1.76x, with a market beta of 0.94. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Avantor a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Avantor (AVTR) the key facts are: market cap $7.5B, revenue $6.6B, 52-week range 7.265-15.93. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.